We thus suggest that downregulation of PAK2 could integrate various signaling pathways that are critical to cell growth and survival, therefore leading to miR‐7‐5p‐mediated inhibition of NSCLC cell proliferation and induction of G0/G1 arrest and apoptosis. Here, PAK2 is linked to non-small cell lung carcinoma.